MOUNTAIN VIEW, Calif., July 10, 2008 (PRIME NEWSWIRE) -- Pharsight Corporation (Nasdaq:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, today announced that Jason Chittenden, MS, Director of Training and Pre-Sales will speak to members of the pharmaceutical and biotechnology industries attending the 35th Annual Meeting and Exposition of the Controlled Release Society, to be held at the New York Hilton in New York City, July 13th-16th, 2008.
